Hydrochloric Acid → (S)-3-(Isoxazol-3-yl)-3-(4-(2-(4-(trifluoromethyl)phenoxy)ethoxy)phenyl)propanoic acid
Reaction equation
C([C@H]1COC(=O)N1[C:14](=[O:42])[CH2:15][C@H:16]([C:37]1[CH:41]=[CH:40][O:39][N:38]=1)[C:17]1[CH:22]=[CH:21][C:20]([O:23][CH2:24][CH2:25][O:26][C:27]2[CH:32]=[CH:31][C:30]([C:33]([F:36])([F:35])[F:34])=[CH:29][CH:28]=2)=[CH:19][CH:18]=1)C1C=CC=CC=1.[OH:43]O.[OH-].[Li+].Cl>C1COCC1.O>[O:39]1[CH:40]=[CH:41][C:37]([C@H:16]([C:17]2[CH:22]=[CH:21][C:20]([O:23][CH2:24][CH2:25][O:26][C:27]3[CH:32]=[CH:31][C:30]([C:33]([F:35])([F:34])[F:36])=[CH:29][CH:28]=3)=[CH:19][CH:18]=2)[CH2:15][C:14]([OH:42])=[O:43])=[N:38]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of the oxazolidinone 47.2 (58.0 mg, 0.1 mmol) dissolved in THF (5 mL), was added a 30% hydrogen peroxide solution (113 μL, 1 mmol) followed by a 2 M lithium hydroxide solution (250 μL, 0.5 mmol). The resulting slurry was stirred for one hour. The reaction mixture was then diluted with water and acidified with hydrochloric acid to pH ˜3. The mixture was then extracted with EtOAc (1×20 mL), and the organic layer was washed with an acidic sodium sulfite solution (2×15 mL) and brine (1×15 mL), and dried over magnesium sulfate. The filtrate was concentrated under reduced pressure, and the residue was purified by reverse phase HPLC to give 47 (23.6 mg). MS ESI (pos.) m/e: 422.0 (M+H). 1H NMR (400 MHz, CD3CN) δ ppm 8.34 (1 H, s), 7.53 (2 H, d, J=8.6 Hz), 7.14 (2 H, d, J=8.6 Hz), 7.00 (2 H, d, J=8.6 Hz), 6.83 (2 H, d, J=8.6 Hz), 6.16 (1 H, d), 4.45 (1 H, t, J=7.8 Hz), 4.25-4.31 (2 H, m), 4.20-4.24 (2 H, m), 3.09 (1 H, dd, J=16.4, 8.2 Hz), 2.84 (1 H, dd, J=16.4, 7.4 Hz).
Workup
- extractionThe mixture was then extracted with EtOAc (1×20 mL)
- washthe organic layer was washed with an acidic sodium sulfite solution (2×15 mL) and brine (1×15 mL)
- dry with materialdried over magnesium sulfate
- concentrationThe filtrate was concentrated under reduced pressure
- customthe residue was purified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-7c62caa2761b4f21a64babbdee0b3bf7
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003648B2
Reaction notes
Loading…